metastatic breast cancer

... out of options in her battle against metastatic breast cancer. A new tumor located in the sacrum, or upper part of the pelvis, was causing intense pain that was spreading and interfering with her ability ...
Tuesday, 23 June 2009
2. BSD Medical to Exhibit At 2009 ACRO Conference
(Radiology Conferences/Conference News)
BSD Medical Corporation announced that the company will be exhibiting at the meeting of the American College of Radiation Oncology (ACRO) being held in Las Vegas, Nevada February 26-28. The conference ...
Thursday, 26 February 2009
Researchers at Georgetown University Medical Center presented a study suggesting a simple blood test can help doctors more reliably assess treatment efficacy for patients with metastatic breast cancer. ...
Tuesday, 30 November 1999
... clinical trials. "Our data support the conclusion that 2ME2 could be an important new therapy in the arsenal to fight metastatic breast cancer," the researchers write. The study is funded by a grant ...
Tuesday, 30 November 1999
... for monitoring metastatic breast cancer. The CellSearch System identifies and counts circulating tumor cells (CTCs) in a blood sample to predict progression-free survival and overall survival in patients ...
Tuesday, 30 November 1999
... used to help decide appropriate therapy for a woman with metastatic breast cancer. Lymph nodes are part of the system that helps protect the body against infection. The first lymph node that filters ...
Tuesday, 30 November 1999
The combination of capecitabine plus trastuzumab is safe and effective for women with heavily pretreated metastatic breast cancer, according to a report in the September 1st issue of the Journal of Clinical ...
Tuesday, 30 November 1999
8. FDA approves new drug for advanced breast cancer
(Communities/Breast Mammary Gland)
... name Xeloda. In certain patients, it may also be used with Xeloda, the FDA said. "We now have an important new option for patients with metastatic breast cancer who have rapidly progressed through currently ...
Tuesday, 30 November 1999
9. Breast cancer therapy response detected early
(Communities/Breast Mammary Gland)
A drop in CTCs indicates that chemotherapy is working in patients with metastatic breast cancer. This can be established after the first cycle of treatment, a Georgetown University team reported. A ...
Tuesday, 30 November 1999
10. Roche files Herceptin in Japan for breast cancer
(Communities/Breast Mammary Gland)
... of operable early-stage HER2-positive breast cancer for Herceptin. The drug is used as a standard therapy for HER2-positive metastatic breast cancer. The group said four large clinical trials had been ...
Tuesday, 30 November 1999
Results of a phase III trial confirm the clinical benefit of combining first-line bevacizumab with taxane chemotherapy for patients with HER2-negative metastatic breast cancer. Results of a phase ...
Tuesday, 30 November 1999
The higher death risk for African American women with metastatic breast cancer persists in clinical trials where overall responses to therapy are similar, according to a report. The higher death risk ...
Tuesday, 30 November 1999
Tags: [metastatic breast cancer,circulating tumor cells,CTC,radiology news,RSNA reviews,Reports and radiology information]  ...
Tuesday, 30 November 1999
Tags: [breast cancer,American Society of Clinical Oncology,HER2-negative metastatic breast cancer,bevacizumab,Tumor shrinkage]  ...
Tuesday, 30 November 1999
Tags: [Clinical Oncology,premenopausal,metastatic breast cancer]  ...
Tuesday, 30 November 1999
Follow us on...
Facebook Page: 174226168059 Linked In Group: 2434026 Twitter: medicexchange